REGULATED PRESS RELEASE published on 05/27/2026 at 17:45, 4 months 22 days ago Report ordinary & special general meeting of May 27, 2026 Gimv's General Meeting approves EUR 1.95 per share dividend for financial year 2025. Annual accounts and directors' discharge also granted. Key appointments announced Gimv Dividend Appointment General Meeting Directors
BRIEF published on 05/27/2026 at 07:35, 4 months 22 days ago Gimv Reports Positive First Quarter Performance for 2026 Credit Facility Investment Strategy Market Challenges Financial Growth Gimv Portfolio
REGULATED PRESS RELEASE published on 05/27/2026 at 07:30, 4 months 22 days ago Trading update Gimv provides a trading update for the first quarter of 2026, showing positive portfolio returns and a new credit facility. Activities include acquisitions, investments, and market expansions Credit Facility Gimv Trading Update Portfolio Returns Market Expansions
BRIEF published on 04/30/2026 at 07:35, 5 months 18 days ago Gimv Acquires 5% Stake in Azelis, Strengthening Its Investment Portfolio Growth Strategy Gimv Investment Specialty Chemicals Azelis
REGULATED PRESS RELEASE published on 04/30/2026 at 07:30, 5 months 18 days ago New Gimv Anchor investment: acquisition of 5% shareholding in Azelis Gimv Anchor invests in Azelis with 5% shareholding, aiming to support strategic growth plans. Partnership to boost innovation, sustainability, and M&A in specialty chemical market Investment Strategic Growth Gimv Anchor Azelis Specialty Chemical
BRIEF published on 04/27/2026 at 17:50, 5 months 21 days ago Gimv Announces Agenda for May 2026 General Meeting General Meeting Director Appointments Dividend Approval Gimv Investment Change-of-Control
REGULATED PRESS RELEASE published on 04/27/2026 at 17:45, 5 months 21 days ago Convocation annual general meeting of May 27, 2026 Gimv invites shareholders to its annual general meeting on May 27, 2026, to approve dividend, director reappointments, and change-of-control provisions. Details on www.gimv.com Annual General Meeting Shareholders Gimv Dividend Change-of-control Provisions
BRIEF published on 03/24/2026 at 07:35, 6 months 25 days ago Gimv Secures EUR 400 Million Credit Facility to Boost Growth Growth Strategy Credit Facility Gimv Investment Belgian Banks
REGULATED PRESS RELEASE published on 03/24/2026 at 07:30, 6 months 25 days ago Gimv secures new EUR 400 million revolving credit facility to support accelerated growth ambitions Gimv secures EUR 400 million revolving credit facility to support growth strategy. Leading Belgian banks arrange funding. CEO and CFO express gratitude Growth Strategy Gimv Revolving Credit Facility CEO And CFO Belgian Banks
BRIEF published on 03/05/2026 at 07:35, 7 months 13 days ago Gimv Completes Share Buyback Program Private Equity Share Buyback Gimv Investment Euronext Brussels
Published on 10/17/2026 at 03:20, 2 days 3 hours ago Battery X Metals Highlights Participation at X Takeover 2026, an Electric Vehicle and Emerging Technology Event Held at Tesla's Gigafactory Texas, Providing Exposure to Industry Perspectives and Technology Developments
Published on 10/17/2026 at 03:15, 2 days 4 hours ago Vanta Closes Second Tranche of Private Placement Financing and Welcomes Launch of First U.S.-Listed Peptide ETF, Highlighting Growing Recognition of Peptide Industry
Published on 10/16/2026 at 23:35, 2 days 7 hours ago Initial Closing of US$3.4 Million Private Placement
Published on 10/16/2026 at 23:30, 2 days 7 hours ago NiobiumX Mining Inc. Announces Retraction of Recent Marketing Materials
Published on 10/16/2026 at 23:00, 2 days 8 hours ago Grid Announces Adoption of Advance Notice By-Law and Provides Shareholder Meeting Update
Published on 10/19/2026 at 07:03, 15 minutes ago NORMA Group provides details on NewNORMA strategy and sets financial ambition through 2031
Published on 10/19/2026 at 07:00, 18 minutes ago Julius Baer Appoints Francis Hoefman as Chief Human Resources Officer
Published on 10/19/2026 at 07:00, 18 minutes ago DKSH to Establish a Healthcare Platform in the Middle East and Scale Up Capabilities With the Acquisition of NewBridge Pharmaceuticals
Published on 10/16/2026 at 18:48, 2 days 12 hours ago Disclosure of transactions in own shares from October 12 to October 16, 2026
Published on 10/15/2026 at 18:50, 3 days 12 hours ago September & first 9 months of 2026 traffic figures - Revision of Traffic assumptions for 2026
